Amendment Statement of Principles concerning GUILLAIN-BARRE SYNDROME (Balance of Probabilities) (No. 75 of 2022) The Repatriation Medical Authority determines the following Amendment Statement of Principles under subsections 196B(3) and (8) of the Veterans' Entitlements Act 1986. Dated 24 June 2022 The Common Seal of the Repatriation Medical Authority was affixed to this instrument at the direction of: Professor Terence Campbell AM Chairperson Contents 1 Name 2 Commencement 3 Authority 4 Amendment 1 Name This is the Amendment Statement of Principles concerning Guillain-Barre syndrome (Balance of Probabilities) (No. 75 of 2022). 2 Commencement This instrument commences on 25 July 2022. 3 Authority This instrument is made under subsections 196B(3) and (8) of the Veterans' Entitlements Act 1986. 4 Amendment The Statement of Principles concerning Guillain-Barre syndrome (Balance of Probabilities) (No. 24 of 2018) (Federal Register of Legislation No. F2018L00187) is amended in the following manner: Section Amendment 9(5) Replace the existing factor in subsection 9(5) with the following: receiving a vaccine from the specified list of vaccines within the two months before the clinical onset of Guillain-Barre syndrome; Note: specified list of vaccines is defined in the Schedule 1 – Dictionary. Schedule 1 – Dictionary Insert the following definition of "specified list of vaccines" in alphabetical order: specified list of vaccines means: (a) adenovirus vector coronavirus 2019 (COVID-19) vaccine; (b) influenza vaccine; or (c) nerve tissue derived rabies vaccine. Note: Examples of adenovirus vector COVID-19 vaccines include: (a) Ad26.COV2.S (Janssen COVID-19 Vaccine); (b) ChAdOx1 nCoV-19 (Vaxzevria, Oxford/Astra-Zeneca); (c) Gam-COVID-Vac (Sputnik V, Sputnik Light); and (d) AD5-nCOV (Convidecia).